| abstract |
Disclosed is a pharmaceutical composition of 2,4,6-trifluoro-N- [6- (1-methyl-piperidin-4-ylcarbonyl) -pyridin-2-yl] -benzamide. It comprises 2,4,6-trifluoro-N- [6- (1-methyl-piperidin-4-ylcarbonyl) -pyridin-2-yl] -benzamide and a pharmaceutically acceptable carrier. A pharmaceutical composition, for oral or rectal administration, said composition comprises 50 to 400 mg of said compound or a pharmaceutically acceptable salt thereof per dose, buccal, sublingual, nasal / nasal, transdermal, subcutaneous For injection, intravenous or intramuscular administration, the composition comprises up to 200 mg of compound or pharmaceutically acceptable salt thereof per dose, and is administered 1, 2 or 3 times a day. [Selection figure] None |